ÂÜÀòÉç

Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.

7th Annual Pharmacovigilance Asia 2016

20 September 2016 08:00 - 21 September 2016 18:00, Singapore, Singapore


Introduction
The 7th Annual Pharmacovigilance Asia Summit once again gathers global and regional regulators together with industry experts to tackle the latest challenges in proactively building and managing a risk-management programme. What are the new quantitative methods in benefit-risk evaluation?  How do you create a PV-focused culture and what is the role of the QPPV in Asia? How has digital health initiatives had an impact on the cost and accuracy of PV?  How do you leverage on mobile applications to enhance medication adherence and patient support compliance?  

We’ll be answering these questions and more as we bring together experts from Europe and APAC!   

Key Topics To Be Addressed in 2016 Include:
The latest PV legislation – how will developments in US and Europe affect Asia? 
Leveraging digital health applications to enhance patient support through detecting and managing safety signals and enhance patient support 
Pro-actively negotiating risk management plans and benefit-risk evaluation in Asia – both quantitative and qualitative approaches
Creating a PV-focused culture and ensuring quality assurance across people, process and technologies
Ensuring continuity and compliance  in M and A environment 
How to effectively communicate risk through education, awareness, and collaboration  with the community 

For more information please email enquiry@iqpc.com  or call +65 6722 9388

Useful links

Venue
TBC

TBC, Singapore, Singapore, 0000, Singapore

Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*